CV Sciences, Inc. (OTCMKTS:CVSI) Sees Large Drop in Short Interest

CV Sciences, Inc. (OTCMKTS:CVSI) was the target of a significant decline in short interest during the month of December. As of December 31st, there was short interest totalling 6,400 shares, a decline of 82.5% from the December 15th total of 36,600 shares. Based on an average daily volume of 697,100 shares, the days-to-cover ratio is currently 0.0 days.

CV Sciences Price Performance

CVSI stock traded up $0.00 during midday trading on Wednesday, reaching $0.03. The company had a trading volume of 108,551 shares, compared to its average volume of 367,295. The firm has a 50-day moving average price of $0.04 and a 200-day moving average price of $0.04. The company has a market capitalization of $6.28 million, a P/E ratio of -3.40 and a beta of 0.66. CV Sciences has a 1 year low of $0.03 and a 1 year high of $0.10.

About CV Sciences

CV Sciences, Inc develops, manufactures, markets, and sells herbal supplements and hemp-based cannabidiol (CBD) in North America. It operates in two segments, Consumer Products and Specialty Pharmaceutical. The company offers its products under the PlusCBD, ProCBD, HappyLane, CVAcute, CVDefense, and PlusCBD Pet brands in the health care market sector, including nutraceutical, beauty care, specialty foods, and pet products through its websites, elect distributors, brick and mortar retailers, and select e-tailers.